Yahoo Malaysia Web Search

Search results

  1. 1 day ago · Findlay Park Partners LLP bought a new position in shares of Illumina, Inc. (NASDAQ:ILMN – Free Report) during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 729,100 shares of the life sciences company’s stock, valued at approximately $100,120,000.

  2. 3 days ago · Health Care Pharmaceuticals and Biotechnology. Price (USD) 105.28. Today's Change -0.23 / -0.22%. Shares traded 986.67k. 1 Year change -42.41%. Beta 1.1543. Data delayed at least 15 minutes, as of Jul 03 2024 18:00 BST. Improved Notifications for Markets Data Alerts.

  3. 3 days ago · July 3, 2024. Illumina, Inc. ( NASDAQ:ILMN - Get Free Report) was the target of a large drop in short interest in June. As of June 15th, there was short interest totalling 5,140,000 shares, a drop of 11.7% from the May 31st total of 5,820,000 shares. Based on an average trading volume of 2,480,000 shares, the days-to-cover ratio is presently 2. ...

  4. 2 days ago · Illumina, Inc. has a 12 month low of $89.00 and a 12 month high of $195.64. Illumina (NASDAQ:ILMN – Get Free Report) last issued its quarterly earnings results on Thursday, May 2nd. The life ...

  5. 8 hours ago · Illumina, Inc.’s stock price stands strong at 108.52 USD, showcasing a positive trading session with a 3.08% hike, backed by a robust trading volume of 1.37M. Despite a YTD percentage change of -19.80%, ILMN’s stock performance continues to pique investor interest.

  6. 1 day ago · Findlay Park Partners LLP purchased a new position in Illumina, Inc. ( NASDAQ:ILMN - Free Report) during the first quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 729,100 shares of the life sciences company's stock, valued at approximately $100,120,000.

  7. 4 days ago · The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 56.73 times its estimated earnings per share for the ongoing year. With an enterprise value anticipated at 3.93 times the sales for the current fiscal year, the company turns out to be overvalued. In relation to the value of its tangible ...